Cargando…

Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia

Millions of people suffer with dementia worldwide. However, early diagnosis of neurodegenerative diseases/dementia (NDD) is difficult, and no specific biomarkers have been found. This study aims to review the applications of salivary metabolomics in diagnostics and the treatment monitoring of NDD A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyvärinen, Eelis, Solje, Eino, Vepsäläinen, Jouko, Kullaa, Arja, Tynkkynen, Tuulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968225/ https://www.ncbi.nlm.nih.gov/pubmed/36837852 http://dx.doi.org/10.3390/metabo13020233

Ejemplares similares

Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities
por: Hyvärinen, Eelis, et al.
Publicado: (2021)

Oral Sources of Salivary Metabolites
por: Hyvärinen, Eelis, et al.
Publicado: (2023)

State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm
por: Solje, Eino, et al.
Publicado: (2021)

Metabolome of canine and human saliva: a non-targeted metabolomics study
por: Turunen, Soile, et al.
Publicado: (2020)

Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
por: Schepici, Giovanni, et al.
Publicado: (2020)

Proof of concept for quantitative urine NMR metabolomics pipeline for large-scale epidemiology and genetics
por: Tynkkynen, Tuulia, et al.
Publicado: (2019)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
por: Giunta, Marcello, et al.
Publicado: (2021)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Characteristics of Normalization Methods in Quantitative Urinary Metabolomics—Implications for Epidemiological Applications and Interpretations
por: Li, Tianqi, et al.
Publicado: (2022)

Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy
por: Maszka, Patrycja, et al.
Publicado: (2023)

Salivary Redox Biomarkers in Selected Neurodegenerative Diseases
por: Maciejczyk, Mateusz, et al.
Publicado: (2020)

Salivary Metabolomics for Systemic Cancer Diagnosis: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2022)

Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis
por: Londoño, Diana P, et al.
Publicado: (2022)

(1)H NMR Based Metabolomics in Human Sepsis and Healthy Serum
por: Jaurila, Henna, et al.
Publicado: (2020)

Salivary biomarkers for the diagnosis and monitoring of neurological diseases
por: Farah, Raymond, et al.
Publicado: (2018)

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
por: Cajanus, Antti, et al.
Publicado: (2018)

Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2022)

Strategies for molecular imaging dementia and neurodegenerative diseases
por: Schaller, Bernhard J
Publicado: (2008)

Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
por: Murray, Melissa E, et al.
Publicado: (2014)

Apraxias in Neurodegenerative Dementias
por: Chandra, Sadanandavalli Retnaswami, et al.
Publicado: (2015)

Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies
por: Melguizo-Rodríguez, Lucía, et al.
Publicado: (2020)

Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
por: Katisko, Kasper, et al.
Publicado: (2019)

Value-Generating Exploratory Trials in Neurodegenerative Dementias
por: Friedman, Lauren G., et al.
Publicado: (2021)

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018)

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
por: Huber, Nadine, et al.
Publicado: (2021)

Early Diagnosis and Monitoring of Neurodegenerative Langerhans Cell Histiocytosis
por: Sieni, Elena, et al.
Publicado: (2015)

Qualitative and Quantitative Mass Spectrometry in Salivary Metabolomics and Proteomics
por: Grocholska, Paulina, et al.
Publicado: (2023)

Concentric Ring Probe for Bioimpedance Spectroscopic Measurements: Design and Ex Vivo Feasibility Testing on Pork Oral Tissues
por: Emran, Shekh, et al.
Publicado: (2018)

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
por: Cajanus, Antti, et al.
Publicado: (2019)

Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases
por: Sharma, Vaibhav, et al.
Publicado: (2023)

Cognitive and behavioural inhibition deficits in neurodegenerative dementias
por: Migliaccio, Raffaella, et al.
Publicado: (2020)

Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review
por: Rammos, Aidonis, et al.
Publicado: (2021)

Unexpected degradation of the bisphosphonate P-C-P bridge under mild conditions
por: Turhanen, Petri A, et al.
Publicado: (2008)

Synthesis of novel (1-alkanoyloxy-4-alkanoylaminobutylidene)-1,1-bisphosphonic acid derivatives
por: Turhanen, Petri A, et al.
Publicado: (2006)

catena-Poly[[diaquacadmium(II)]-μ-(methyl morpholino dichloromethylenediphosphonato)-κ(3) O,O′:O′′-[tetraaquacadmium(II)]-μ-(methyl morpholino dichloromethylenediphosphonato)-κ(3) O:O′,O′′]
por: Jokiniemi, Jonna, et al.
Publicado: (2009)

Salivary biomarker development using genomic, proteomic and metabolomic approaches
por: Bonne, Nicolai J, et al.
Publicado: (2012)

Salivary Metabolomics for Oral Cancer Detection: A Narrative Review
por: Panneerselvam, Karthika, et al.
Publicado: (2022)

Neuroimaging in the early diagnosis of neurodegenerative disease
por: Stoessl, A Jon
Publicado: (2012)

Low-Dose Doxycycline Treatment Normalizes Levels of Some Salivary Metabolites Associated with Oral Microbiota in Patients with Primary Sjögren’s Syndrome
por: Herrala, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qf3mf7ceh9nb5f3eej06jqnvdf